Nevertheless, in the settings studied, we propose that redox-dependent reactions with C118 of wild-type KRAS activate the protein to stimulate xenograft tumor growth of oncogenic HRASG12V-driven cell lines. This evidence concerns the gene KRAS and neoplasm.